Results 311 to 320 of about 2,458,624 (375)

Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit.

JAMA Netw Open
Weiner SG, Little K, Yoo J, Flores DP, Hildebran C, Wright DA, Ritter GA, El Ibrahimi S.   +7 more
europepmc   +1 more source

Unmet need for medication for opioid use disorder among persons who inject drugs in 23 U.S. cities. [PDF]

Drug Alcohol Depend
Handanagic S, Broz D, Finlayson T, Kanny D, Wejnert C, NHBS Study Group.   +5 more
europepmc   +1 more source

Emergency department–initiated oral naltrexone for patients with moderate to severe alcohol use disorder: A pilot feasibility study

Academic Emergency Medicine, Volume 32, Issue 5, Page 488-497, May 2025.
Abstract Objectives Alcohol use disorder (AUD) is the most common substance use disorder in the United States. Despite availability of four FDA‐approved medications, fewer than 10% of patients are prescribed medication. This study aimed to evaluate the impact and feasibility of emergency department (ED)‐initiated oral naltrexone in patients with ...
Ethan Cowan, Clare O'Brien‐Lambert, Erick Eiting, Edward Bull, Jacqueline Ryder, Yvette Calderon, Edwin Salsitz   +6 more
wiley   +1 more source

Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties. [PDF]

Epidemiology
Cerdá M, Hamilton AD, Hyder A, Rutherford C, Bobashev G, Epstein JM, Hatna E, Krawczyk N, El-Bassel N, Feaster DJ, Keyes KM.   +10 more
europepmc   +1 more source

Racial, ethnic, and sex disparities in buprenorphine treatment from emergency departments by discharge diagnosis

Academic Emergency Medicine, EarlyView.
Abstract Objectives Racial and sex disparities are noted in the administration and prescribing of buprenorphine from emergency departments (EDs) nationally. It is unknown whether disparities persist when accounting for the specific discharge diagnosis addressed during encounters such as opioid overdose or withdrawal.
Neeraj Chhabra, Dale Smith, Natalie Parde, Nicole Hsing‐Smith, Joseph M. Bianco, R. Andrew Taylor, Gail D'Onofrio, Niranjan S. Karnik   +7 more
wiley   +1 more source

The impact of chronic pain and depression on medication for opioid use disorder treatment: A mixed-methods analysis. [PDF]

Heroin Addict Relat Clin Probl
Kacmarek CN, Smith HC, Kuehn M, Bennett ME, Belcher A, Fitzsimons H, Hall W, Greenblatt A, Li L, Travaglini LE.   +9 more
europepmc   +1 more source

Examining the predictive validity of alcohol‐seeking following punishment‐imposed abstinence in mice

Alcohol, Clinical and Experimental Research, EarlyView.
Animal models of alcohol use disorder are critical to understand the neurochemical mechanisms underlying this disorder to inform targeted medication development. However, quite often the validity of commonly used animal models remains untested. Here, we optimized a highly used model of abstinence in mice and demonstrated the predictive validity of the ...
Linh Tran, Maria Kuznetsova, Elizabeth E. Manning, Erin J. Campbell   +3 more
wiley   +1 more source

Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study. [PDF]

Harm Reduct J
McKellar MS, Des Marais AC, Chen H, Choi Y, Lilly R, Ayers D, Bennett J, Kestner L, Perry B, Poley S, Corneli A, Meade CS, Sachdeva N.   +12 more
europepmc   +1 more source

Mental Health and the Constitution: How Incarcerating the Mentally Ill Might Pave the Way to Treatment

, 2020
Caspar, Samantha M., Joukov, Artem M.
core